JP Morgan maintains Legend Biotech at neutral, cuts target to $33
JP Morgan maintained Legend Biotech at neutral and cut its price target to $33.00 from $35.00, per Benzinga’s ratings update.
Story updates
08:18:57 PM UTC
SquawkNews
Legend Biotech Price Target Cut to $33.00/Share From $35.00 by JP Morgan